Xcout Intel
Epitopea
Epitopea is a transatlantic cancer immunotherapeutics company operating from Montreal, Canada, and Cambridge, United Kingdom. Backed by life-science investors, the company develops novel therapeutics utilizing its proprietary CryptoMap platform.
Subscribe to see Epitopea’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Epitopea at a glance
Epitopea is a biotechnology company headquartered in Canada. It has raised at least $45M across the 2 funding rounds on record. Its most recent funding round, Pre-Series A, raised $31M in October 2024. Xcout tracks 5 named people at Epitopea, including Dr. Alan C. Rigby (CEO).
Epitopea leadership
- Dr. Alan C. RigbyCEO
- Klaus EdvardsenCMO
- Claude PerreaultFounder
- Pierre ThibaultFounder
- Bryan KellyVice-President, Finance
Epitopea funding rounds
At least $45M raised across the 2 rounds on record. Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Pre-Series A | $31M | 11 named | |
| — | $14M | 11 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Investors
Epitopea competitors
A few of Epitopea's closest competitors — see the full list of competitors and alternatives →
Enara Bio, Ltd. is a UK biotechnology company that discovers cancer targets, including tumor-specific antigens, using immunopeptidomics and machine-learning technologies. It works with biopharmaceutical companies to support development of cancer vaccines and other targeted immunotherapies.
Nested Therapeutics is a privately held biotech company headquartered in Cambridge, Massachusetts, focused on advancing precision oncology medicine by uncovering hidden driver mutations.
Actithera, Inc. is a biotechnology company based in Cambridge, Massachusetts, focused on delivering targeted radioligand cancer therapies.
Immatics is a biopharmaceutical company that develops T cell-based immunotherapies and bispecific product candidates to treat various types of cancer. The company focuses on precision targeting of the PRAME protein expressed in multiple solid tumors, serving cancer patients with high unmet medical needs.
Elicera Therapeutics is a clinical-stage immuno-oncology company that develops genetically engineered cell and gene therapies, including CAR T-cell therapies and oncolytic viruses, to treat various types of cancer. The company utilizes its proprietary iTANK technology platform to enhance the immune system's ability to target and attack solid tumors.
Neogap Therapeutics is a privately held clinical-stage biopharmaceutical company founded in 2016 and located at the Cancer Center Karolinska in Stockholm, Sweden. The company focuses on immuno-oncology and is developing personalized therapies for cancer treatment.
Get Epitopea's news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Epitopea in Xcout Intel
- 5 named people with titles, LinkedIn and board committees
- 2 funding rounds with the investors in each, and who they co-invest with
- The full competitor set, tracking, exports and API access